Deinove (EG: ALDEI)

Last close As at 02/03/2024

0.64

0.00 (0.00%)

Market capitalisation

14m

Edison Investment Research is terminating coverage on Deinove. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

View More

Healthcare | Update

Deinove — Phase II study with DNV3837 for C. diff starts

Healthcare | Update

Deinove — Steady progress on all fronts

Healthcare | Update

Deinove — Preparing for DNV3837 Phase II trial start

Healthcare | Outlook

Deinove — Diversified biotech championing antibiotics

Financials

Edison Investment Research is terminating coverage on Deinove. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Research

Outlook

Healthcare

Deinove — Diversified biotech championing antibiotics

Update

Healthcare

Deinove — Cash conservation and operational progress

Update

Healthcare

Deinove — Progress implementing the new strategy

Update

Healthcare

Deinove — Update 3 October 2016

Outlook

Healthcare

Deinove — Update 10 June 2016

Update

Healthcare

Deinove — Update 30 March 2016

Update

Healthcare

Deinove — Update 11 January 2016

Flash note

Healthcare

Deinove — Update 1 December 2015

Thematics

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

thematic

Healthcare

ASCO 2023 key takeaways

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free